Follow
Katjusa Koler
Katjusa Koler
Verified email at sheffield.ac.uk
Title
Cited by
Cited by
Year
The pathway coexpression network: revealing pathway relationships
Y Pita-Juárez, G Altschuler, S Kariotis, W Wei, K Koler, C Green, RE Tanzi, ...
PLoS computational biology 14 (3), e1006042, 2018
512018
Most pathways can be related to the pathogenesis of alzheimer’s disease
SL Morgan, P Naderi, K Koler, Y Pita-Juarez, D Prokopenko, IS Vlachos, ...
Frontiers in Aging Neuroscience 14, 846902, 2022
192022
GCH1 deficiency activates brain innate immune response and impairs tyrosine hydroxylase homeostasis
H Larbalestier, M Keatinge, L Watson, E White, S Gowda, W Wei, K Koler, ...
Journal of Neuroscience 42 (4), 702-716, 2022
182022
Systems analysis of Alzheimer’s disease pathway dysregulation in human subjects is recapitulated in 3d cellular models to reveal P38 MAPK as a therapeutic target that mitigates …
PN Yeganeh, SS Kwak, M Jorfi, L Quinti, K Koler, Y Choi, J Park, ...
Alzheimer's & Dementia 19, e063716, 2023
2023
Most Pathways Can Be Related to the Pathogenesis of Alzheimer’s
SL Morgan, P Naderi, K Koler, Y Pita-Juarez, D Prokopenko, IS Vlachos, ...
Progress of Translational Medicine in Alzheimer's Disease, 2022
2022
A systematic pathway-based network approach for in silico drug repositioning
K Koler
University of Sheffield, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–6